You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萊美藥業(300006.SZ):公司實控人變更為廣西國資委
格隆匯 04-08 19:12

格隆匯4月8日丨萊美藥業(300006.SZ)公佈,近日,公司獲悉中恆集團已收到廣西壯族自治區人民政府國有資產監督管理委員會(“廣西國資委”)出具的《自治區國資委關於廣西梧州中恆集團股份有限公司收購重慶萊美藥業股份有限公司有關問題的批覆》(桂國資復[2020]31號),同意中恆集團收購萊美藥業方案。

中恆集團已收到國家市場監督管理總局出具的《經營者集中反壟斷審查不實施進一步審查決定書》(反壟斷審查決定[2020]135號),決定書顯示:經初步審查,對廣西梧州中恆集團股份有限公司通過合同及股份收購方式取得重慶萊美藥業股份有限公司的控制權案不實施進一步審查。中恆集團從即日起可以實施集中。

邱宇與中恆集團簽署的《表決權委託協議》已滿足生效條件,中恆集團成為公司單一擁有表決權份額最大的股東,公司實際控制人變更為廣西國資委。

截止公告披露日,中恆集團直接持有公司股份3631.4953萬股,佔公司總股本的4.47%。此次《表決權委託協議》生效後,中恆集團在公司中擁有表決權的股份數量合計約2.2081億股,佔公司總股本的27.19%。

截至公告披露日,廣西投資集團有限公司(“廣投集團”)持有中恆集團26.00%的股權,廣西壯族自治區人民政府授權廣西國資委對中恆集團依法履行出資人職責,廣西國資委為中恆集團的實際控制人。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account